Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 689,000 | 1,296,000 | 671,000 | 260,000 | 180,000 |
| Marketable Securities | 159,000 | 344,000 | 81,000 | N/A | N/A |
| Receivables | 932,000 | 900,000 | 542,000 | 435,000 | 370,000 |
| Inventories | 418,000 | 360,000 | 281,000 | 243,000 | 303,000 |
| Income taxes - deferred | 152,000 | 241,000 | 245,000 | 168,000 | 174,000 |
| TOTAL | $2,631,000 | $3,289,000 | $1,880,000 | $1,208,000 | $1,106,000 |
| Non-Current Assets | |||||
| PPE Net | 1,011,000 | 870,000 | 744,000 | 636,000 | 592,000 |
| Investments And Advances | 594,000 | 529,000 | 558,000 | 210,000 | 154,000 |
| Intangibles | 3,735,000 | 3,340,000 | 2,461,000 | 2,367,000 | 2,064,000 |
| Other Non-Current Assets | 225,000 | 142,000 | 56,000 | 29,000 | 58,000 |
| TOTAL | $5,565,000 | $4,881,000 | $3,819,000 | $3,242,000 | $2,868,000 |
| Total Assets | $8,196,000 | $8,170,000 | $5,699,000 | $4,450,000 | $3,974,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,000 | 502,000 | 1,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 105,000 | 108,000 | 78,000 | 66,000 | 54,000 |
| Accrued Expenses | 1,124,000 | 902,000 | 597,000 | 639,000 | 421,000 |
| Other current liabilities | 77,000 | 112,000 | 80,000 | 28,000 | 10,000 |
| TOTAL | $1,479,000 | $2,605,000 | $1,393,000 | $923,000 | $831,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,864,000 | 1,139,000 | 1,172,000 | 847,000 | 973,000 |
| Other Non-Current Liabilities | 309,000 | 142,000 | 121,000 | 113,000 | 112,000 |
| TOTAL | $2,435,000 | $1,540,000 | $1,444,000 | $1,060,000 | $1,128,000 |
| Total Liabilities | $3,914,000 | $4,145,000 | $2,837,000 | $1,983,000 | $1,959,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 821,567 | 838,757 | 833,118 | 819,896 | 805,589 |
| Common Shares | 8,000 | 8,000 | 8,000 | 4,000 | 4,000 |
| Retained earnings | 3,410,000 | 2,790,000 | 1,789,000 | 1,394,000 | 1,031,000 |
| Other shareholders' equity | -77,000 | -86,000 | -49,000 | -127,000 | -72,000 |
| TOTAL | $4,282,000 | $4,025,000 | $2,862,000 | $2,467,000 | $2,015,000 |
| Total Liabilities And Equity | $8,196,000 | $8,170,000 | $5,699,000 | $4,450,000 | $3,974,000 |